Skip to main content
A. Taylor Kelley

A. Taylor Kelley, MD, MPH, MS

Languages spoken: English, Spanish
  • A. Taylor Kelley, MD, MPH, MSc, is an assistant professor in the Division of General Internal Medicine and a primary care physician in the Vulnerable Veteran Innovative Patient-Aligned Care Team Initiative (VIP) clinic at the Salt Lake City VA. As a general internist and pediatrician, his research interests include access to care for vulnerable populations, with focus on immigrants, veterans, and individuals covered by Medicaid.

    Dr. Kelley received undergraduate degree from Brigham Young University and his medical degree from the University of Texas McGovern Medical School at Houston. He completed residency training in internal medicine and pediatrics at Yale-New Haven Hospital and a health services research fellowship in the National Clinician Scholars Program at the University of Michigan. He holds a master of public health degree from Harvard and master of science degree in health care research from the University of Michigan. He is a board certified by the American Board of Internal Medicine.

  • A. Taylor Kelley, MD, MPH, MSc, is an assistant professor in the Division of General Internal Medicine and a primary care physician in the Vulnerable Veteran Innovative Patient-Aligned Care Team Initiative (VIP) clinic at the Salt Lake City VA. As a general internist and pediatrician, his research interests include access to care for vulnerable populations, with focus on immigrants, veterans, and individuals covered by Medicaid.

    Dr. Kelley received undergraduate degree from Brigham Young University and his medical degree from the University of Texas McGovern Medical School at Houston. He completed residency training in internal medicine and pediatrics at Yale-New Haven Hospital and a health services research fellowship in the National Clinician Scholars Program at the University of Michigan. He holds a master of public health degree from Harvard and master of science degree in health care research from the University of Michigan. He is a board certified by the American Board of Internal Medicine.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary

    Education history

    Graduate Training Health and Health Care Research - University of Michigan M.S.
    VA Scholar, National Clinician Scholars Program - VA Ann Arbor Healthcare System/University of Michigan Postdoctoral Scholar
    Internship/Residency Internal Medicine and Pediatrics - Yale New Haven Hospital Intern/Resident
    Health Policy and Management - Harvard T.H. Chan School of Public Health M.P.H.
    Professional Medical Medicine - McGovern Medical School at the University of Texas Health Science Center at Houston M.D.
    Major: Economics; Minor: Music - Brigham Young University B.A.

    Selected Publications

    Journal Article

    1. Kelley AT, Incze MA, Baylis JD, Calder SG, Weiner SJ, Zickmund SL, Jones AL, Vanneman ME, Conroy MB, Gordon AJ, Bridges JFP (In Press.). Patient-centered quality measurement for opioid use disorder: development of a taxonomy to address gaps in research and practice. (Epub ahead of print) Subst Abus.
    2. Incze MA, Kelley AT, Singer PM (2023). Implementing the White House's Strategic Plan to Save Lives Amid the Opioid Crisis: Reaching for the "North Star". JAMA, 329(9), 705-706.
    3. Vanneman ME, Rosen AK, Wagner TH, Shwartz M, Gordon SH, Greenberg G, Zheng T, Cook J, Beilstein-Wedel E, Greene T, Kelley AT (2022). Differences Between VHA-Delivered and VHA-Purchased Behavioral Health Care in Service and Patient Characteristics. Psychiatr Serv, 74(2), 148-157.
    4. Kelley AT, Wilcox J, Baylis JD, Crossnohere NL, Magel J, Jones AL, Gordon AJ, Bridges JFP (2022). Increasing Access to Buprenorphine for Opioid Use Disorder in Primary Care: an Assessment of Provider Incentives. J Gen Intern Med.
    5. Incze MA, Kelley AT, Johnson K (2022). Reexamining Medicaid Patient Review and Restriction Programs Amid the Evolving Opioid Epidemic. JAMA Intern Med.
    6. Kelley AT, Smid MC, Baylis JD, Charron E, Begaye LJ, Binns-Calvey A, Archer S, Weiner S, Pettey W, Cochran G (2021). Treatment access for opioid use disorder in pregnancy among rural and American Indian communities. J Subst Abuse Treat, 136, 108685.
    7. Incze MA, Kelley AT, Gordon AJ (2022). Champions Among Us: Leading Primary Care to the Forefront of Opioid Use Disorder Treatment. J Gen Intern Med, 37(7), 1771-1773.
    8. Radmall AO, Calder S, Codell N, Kelley AT, Hawkins E, Jones AL, Hagedorn HJ, Reynolds MA, Gordon AJ (2022). Roles and Perceptions of Nurses During Implementation of a Medication Treatment for Opioid Use Disorder National Initiative. J Addict Nurs, 33(2), 70-79.
    9. Jones AL, Kelley AT, Suo Y, Baylis JD, Codell NK, West NA, Gordon AJ (2022). Trends in Health Service Utilization After Enrollment in an Interdisciplinary Primary Care Clinic for Veterans with Addiction, Social Determinants of Health, or Other Vulnerabilities. J Gen Intern Med, 38(1), 12-20.
    10. Baylis JD, Charron E, Archer S, Garets M, Bryan MA, Foringer J, Kelley AT, Smid MC, Cochran G (2022). Attitudes, self-efficacy, and practices related to opioid risk assessment and mitigation: A comparison of health care professionals in rural communities. Subst Abus, 43(1), 1163-1171.
    11. Williams AR, Johnson KA, Thomas CP, Reif S, Socas EM, Henry BF, Neighbors C, Gordon AJ, Horgan C, Nosyk B, Drexler K, Krawczyk N, Gonsalves GS, Hadland SE, Stein BD, Fishman M, Kelley AT, Pincus HA, Olfson M (2022). Opioid use disorder Cascade of care framework design: A roadmap. Subst Abus, 43(1), 1207-1214.
    12. Incze MA, Kelley AT, Singer PM (2021). Heterogeneous State Cannabis Policies: Potential Implications for Patients and Health Care Professionals. JAMA, 326(23), 2363-2364.
    13. Kelley AT, Dungan MT, Gordon AJ (2020). Barriers and Facilitators to Buprenorphine Prescribing for Opioid Use Disorder in the Veterans Health Administration During COVID-19. J Addict Med, 15(5), 439-440.
    14. Incze MA, Kelley AT, Gordon AJ (2021). Improving Opioid Use Disorder Treatment through Quality Assessment. J Gen Intern Med, 36(9), 2820-2822.
    15. Kelley AT, Smid MC, Baylis JD, Charron E, Binns-Calvey AE, Archer S, Weiner SJ, Begaye LJ, Cochran G (2021). Development of an unannounced standardized patient protocol to evaluate opioid use disorder treatment in pregnancy for American Indian and rural communities. Addict Sci Clin Pract, 16(1), 40.
    16. Gordon SH, Beilstein-Wedel E, Rosen AK, Zheng T, Kelley AT, Cook J, Zahakos SS, Wagner TH, Vanneman ME (2021). County-level Predictors of Growth in Community-based Primary Care Use Among Veterans. Med Care, 59(Suppl 3), S301-S306.
    17. Codell N, Kelley AT, Jones AL, Dungan MT, Valentino N, Holtey AI, Knight TJ, Butz A, Gallop C, Erickson S, Patton J, Hyte-Richins LJ, Rollins BZ, Gordon AJ (2020). Aims, development, and early results of an interdisciplinary primary care initiative to address patient vulnerabilities. Am J Drug Alcohol Abuse, 47(2), 160-169.
    18. Yu M, Kelley AT, Morgan AU, Duong A, Mahajan A, Gipson JD (2020). Challenges for Adult Undocumented Immigrants in Accessing Primary Care: A Qualitative Study of Health Care Workers in Los Angeles County. Health Equity, 4(1), 366-374.
    19. Kelley AT, Greenstone CL, Kirsh SR (2019). Defining Access and the Role of Community Care in the Veterans Health Administration. J Gen Intern Med, 35(5), 1584-1585.
    20. Kelley AT, Tipirneni R, Levy H (2019). Changes in Veterans' Coverage and Access to Care Following the Affordable Care Act, 2011-2017. Am J Public Health, 109(9), 1233-1235.
    21. Kelley AT, Turner J, Doolittle B (2018). Barriers to Advance Care Planning in End-Stage Renal Disease: Who is to Blame, and What Can be Done? New Bioeth, 24(2), 150-157.
    22. Kelley AT, Tipirneni R (2018). Care for Undocumented Immigrants - Rethinking State Flexibility in Medicaid Waivers. N Engl J Med, 378(18), 1661-1663.

    Review

    1. Kelley AT, Incze MA, Baylis JD, Calder SG, Weiner SJ, Zickmund SL, Jones AL, Vanneman ME, Conroy MB, Gordon AJ, Bridges JFP (2023). Patient-centered quality measurement for opioid use disorder: Development of a taxonomy to address gaps in research and practice. [Review]. Subst Abus, 43(1), 1286-1299.

    Editorial

    1. Kelley AT, Weiner SJ, Francis J (2022). Directly Observed Care: Crossing the Chasm of Quality Measurement. J Gen Intern Med, 38(1), 203-207.

    Letter

    1. Kelley AT, Incze MA (2022). The need for a more inclusive and objective approach in developing a core outcomes set for opioid use disorder. [Letter to the editor]. Addiction, 118(1), 194-195.
  • News & Podcasts